Moreover, miR‐125a‐5p demonstrates significant ties to metabolic derangements, notably ameliorating glycolipid metabolic abnormalities in type 2 diabetes mellitus through STAT3 modulation [28]. The gene discussed is STAT3; the disease is type 2 diabetes mellitus.